Member Info for ogm4

Opportunities in the US?...

And also sounding confident about rolling out AIHL across the entire nation:

"We also expect a number of early adopters to acquire the test to facilitate neonate testing in the very near future. Commercial sales forces have been fully trained and have commenced their sales processes referencing off the new Manchester installation. We have confidence in their ability to target the right experts to allow mainstream adoption in the NHS."

HY report sounded somewhat bullish. Let's see what the next few weeks will bring in terms of news flow and sales contracts.

"We have also made significant further progress with our AIHL system, establishing initial installations and generating significant evidence and support to make commercial progress. We believe the Company is well positioned to deliver on shareholder value; we have managed our cash position carefully and are poised to progress with our expanded portfolio. "

https://mobile.twitter.com/genedriveplc/status/1521840955451711489

genedrive plc

@genedriveplc

·

24 m

Take a look at the first edition of the Genomics in Practice newsletter for GP's and professionals in general practice

https://mobile.twitter.com/genedriveplc/status/1519678752053153792

https://mobile.twitter.com/genedriveplc/status/1519660855637467137

https://mobile.twitter.com/genedriveplc/status/1518946184945192963

No.2 on the leaders board this morning, always good to get some extra attention.

Would be nice to see a gradual rise to mid-/high thirties this week, prior the upcoming news flow.

Not a very massive sell with only 4x shares, is it?!... :-)

Few pennies

She's breaking through the thirties

Strong support currently

Gamechanger

NHS looking for exploration across entire UK as soon as possible

The beauty here is that the required training between 15 mins and 1 hour is easy and quick to implement. No need to send people on a rather expensive, multiple days training course which would be much harder to justify and much more difficult to schedule in.

AIHL is a winner.

New GDR tweet indeed picking up on it

https://mobile.twitter.com/genedriveplc/status/1514153965012848651

Covid app worth 100 Million

https://www.abc.net.au/news/2022-04-12/pfizer-offers-to-buy-brisbane-company-resapp-covid-app/100980442

Inspiration Healthcare

https://mobile.twitter.com/genedriveplc/status/1513791492434890756

Tweet out

Also further GDR updates to be expected this year on the cardiac front. That could be a true game changer.

The Company has initiated the development of a new stroke
marker test, driven by the obvious efficacy and ease of use
demonstrated by MT-RNR1 for an emergency care setting. Clinical guidelines are already in place in countries recommending the use of genetically guided therapy for anticoagulant delivery. While there are competitive products in the market, in our view these fall short in terms of genetic diversity, usability, and price, all factors that can be addressed with Genedrive® instrumentation and chemistry.

https://mobile.twitter.com/paul_rx8/status/1511270260627886086

Labiotech.eu

https://mobile.twitter.com/Labiotech_eu/status/1512339687557509124

https://mobile.twitter.com/MFT_Research/status/1511974842140082179